Screen-enrich-combine circulating system to prepare MSC/β-TCP for bone repair in fractures with depressed tibial plateau

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Blokker CP, Rorabeck CH, Bourne RB. Tibial plateau fractures. An analysis of the results of treatment in 60 patients. Clin. Orthop. Relat. Res. 182, 193–199 (1984).
  Google Scholar
• 2. Adams JD Jr., Della Rocca GJ. Management of posterior articular depression in tibial plateau fractures. J. Knee Surg. 29(1), 28–33 (2016).
  MedlineGoogle Scholar
• 3. Doht S, Lehnert T, Frey S et al. Effective combination of bone substitute and screws in the jail technique: a biomechanical study of tibial depression fractures. Int. Orthop. 36(10), 2121–2125 (2012).
  MedlineGoogle Scholar
• 4. Segur JM, Torner P, Garcia S, Combalia A, Suso S, Ramon R. Use of bone allograft in tibial plateau fractures. Arch. Orthop. Trauma. Surg. 117(6-7), 357–359 (1998).
  Medline CASGoogle Scholar
• 5. Berkes MB, Little MT, Schottel PC et al. Outcomes of Schatzker II tibial plateau fracture open reduction internal fixation using structural bone allograft. J. Orthop. Trauma. 28(2), 97–102 (2014).
  MedlineGoogle Scholar
• 6. Dumic-Cule I, Pecina M, Jelic M et al. Biological aspects of segmental bone defects management. Int. Orthop. 39(5), 1005–1011 (2015).
  MedlineGoogle Scholar
• 7. Smith CA, Richardson SM, Eagle MJ, Rooney P, Board T, Hoyland JA. The use of a novel bone allograft wash process to generate a biocompatible, mechanically stable and osteoinductive biological scaffold for use in bone tissue engineering. J. Tissue Eng. Regen. Med. 9(5), 595–604 (2015).
  Medline CASGoogle Scholar
• 8. Fowler BL, Dall BE, Rowe DE. Complications associated with harvesting autogenous iliac bone graft. Am. J. Orthop. (Belle Mead NJ). 24(12), 895–903 (1995).
  Medline CASGoogle Scholar
• 9. Costa Mendes L, Sauvigne T, Guiol J. Morbidity of autologous bone harvesting in implantology: literature review from 1990 to 2015. Rev. Stomatol. Chir. Maxillofac. Chir. Orale. 117(6), 388–402 (2016).
  MedlineGoogle Scholar
• 10. Veitch SW, Stroud RM, Toms AD. Compaction bone grafting in tibial plateau fracture fixation. J. Trauma. 68(4), 980–983 (2010).
  MedlineGoogle Scholar
• 11. Rijal G, Shin HI. Human tooth-derived biomaterial as a graft substitute for hard tissue regeneration. Regen. Med. 12(3), 263–273 (2017).
  CASGoogle Scholar
• 12. Simpson D, Keating JF. Outcome of tibial plateau fractures managed with calcium phosphate cement. Injury 35(9), 913–918 (2004).
  Medline CASGoogle Scholar
• 13. Drosos GI, Ververidis A, Babourda EC, Kakagia D, Verettas DA. Calcium sulfate cement in contained traumatic metaphyseal bone defects. Surg. Technol. Int. 22, 313–319 (2012).
  MedlineGoogle Scholar
• 14. Wheeler DL, Cross AR, Eschbach EJ et al. Grafting of massive tibial subchondral bone defects in a caprine model using beta-tricalcium phosphate versus autograft. J. Orthop. Trauma. 19(2), 85–91 (2005).
  MedlineGoogle Scholar
• 15. Rolvien T, Barvencik F, Klatte TO et al. ss-TCP bone substitutes in tibial plateau depression fractures. Knee doi:10.1016/j.knee.2017.06.010 (2017) (Epub ahead of print). • Found that implantation of β-tricalcium phosphate alone did not result in biological degradation of bone substitutes and replacement with regenerated bone in human fractures.
  MedlineGoogle Scholar
• 16. Greenwald AS, Boden SD, Goldberg VM, Khan Y, Laurencin CT, Rosier RN. Bone-graft substitutes: facts, fictions, and applications. J. Bone Joint. Surg. Am. 83-A(Suppl. 2) Pt 2, 98–103 (2001).
  MedlineGoogle Scholar
• 17. Bibbo C, Patel DV. The effect of demineralized bone matrix-calcium sulfate with vancomycin on calcaneal fracture healing and infection rates: a prospective study. Foot Ankle Int. 27(7), 487–493 (2006).
  MedlineGoogle Scholar
• 18. Gan Y, Dai K, Zhang P, Tang T, Zhu Z, Lu J. The clinical use of enriched bone marrow stem cells combined with porous beta-tricalcium phosphate in posterior spinal fusion. Biomaterials 29(29), 3973–3982 (2008). •• Found that nonculture enrichment of autologous marrow mesenchymal stem cells and perioperative combination with porous β-tricalcium phosphate was as effective as autologous bone grafts for bone defect repair.
  Medline CASGoogle Scholar
• 19. Marie PJ, Fromigue O. Osteogenic differentiation of human marrow-derived mesenchymal stem cells. Regen. Med. 1(4), 539–548 (2006).
  CASGoogle Scholar
• 20. Kumar S. Bone defect repair in mice by mesenchymal stem cells. Methods Mol. Biol. 1213, 193–207 (2014).
  MedlineGoogle Scholar
• 21. Li Z, Yang Y, Wang C et al. Repair of sheep metatarsus defects by using tissue-engineering technique. J. Huazhong Univ. Sci. Technolog. Med. Sci. 25(1), 62–67 (2005).
  MedlineGoogle Scholar
• 22. Goriainov V, Mcewan JK, Oreffo RO, Dunlop DG. Application of 3D-printed patient-specific skeletal implants augmented with autologous skeletal stem cells. Regen. Med. 13(3), 283–294 (2018).
  CASGoogle Scholar
• 23. Luangphakdy V, Boehm C, Pan H, Herrick J, Zaveri P, Muschler GF. Assessment of methods for rapid intraoperative concentration and selection of marrow-derived connective tissue progenitors for bone regeneration using the canine femoral multidefect model. Tissue Eng. Part A 22(1-2), 17–30 (2016).
  Medline CASGoogle Scholar
• 24. Muschler GF, Matsukura Y, Nitto H et al. Selective retention of bone marrow-derived cells to enhance spinal fusion. Clin. Orthop. Relat. Res. 432, 242–251 (2005). •• Describes a method of selective retention to rapidly concentrate connective tissue progenitors from fresh bone marrow aspirates using porous matrices as a surface for cell attachment.
  MedlineGoogle Scholar
• 25. Zhuang Y, Gan Y, Shi D, Zhao J, Tang T, Dai K. A novel cytotherapy device for rapid screening, enriching and combining mesenchymal stem cells into a biomaterial for promoting bone regeneration. Sci. Rep. 7(1), 15463 (2017). •• Describes a novel device for rapid incorporation of mesenchymal stem cells from fresh bone marrow aspirates and porous biomaterials.
  MedlineGoogle Scholar
• 26. Russell TA, Leighton RK. Comparison of autogenous bone graft and endothermic calcium phosphate cement for defect augmentation in tibial plateau fractures. A multicenter, prospective, randomized study. J. Bone Joint Surg. Am. 90(10), 2057–2061 (2008).
  MedlineGoogle Scholar
• 27. Lachiewicz PF, Funcik T. Factors influencing the results of open reduction and internal fixation of tibial plateau fractures. Clin. Orthop. Relat. Res. (259), 210–215 (1990).
  MedlineGoogle Scholar
• 28. Rosset P, Deschaseaux F, Layrolle P. Cell therapy for bone repair. Orthop. Traumatol. Surg. Res. 100(1 Suppl.), S107–112 (2014).
  Medline CASGoogle Scholar
• 29. Yamada Y, Nakamura S, Ito K et al. Injectable bone tissue engineering using expanded mesenchymal stem cells. Stem Cells 31(3), 572–580 (2013).
  Medline CASGoogle Scholar
• 30. Chu W, Gan Y, Zhuang Y et al. Mesenchymal stem cells and porous beta-tricalcium phosphate composites prepared through stem cell screen-enrich-combine(-biomaterials) circulating system for the repair of critical size bone defects in goat tibia. Stem Cell Res. Ther. 9(1), 157 (2018).
  Medline CASGoogle Scholar
• 31. Dominici M, Le Blanc K, Mueller I et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8(4), 315–317 (2006).
  Medline CASGoogle Scholar
• 32. Zhao L, Zhao J, Yu J, Sun R, Zhang X, Hu S. In vivo investigation of tissue-engineered periosteum for the repair of allogeneic critical size bone defects in rabbits. Regen. Med. 12(4), 353–364 (2017).
  CASGoogle Scholar
• 33. Logeart-Avramoglou D, Anagnostou F, Bizios R, Petite H. Engineering bone: challenges and obstacles. J. Cell. Mol. Med. 9(1), 72–84 (2005).
  Medline CASGoogle Scholar
• 34. Hernigou P, Poignard A, Beaujean F, Rouard H. Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. J. Bone Joint Surg. Am. 87(7), 1430–1437 (2005). • Reviews the evidence in support of grafting concentrated bone marrow cells as an effective and safe method of promoting bone repair.
  MedlineGoogle Scholar
• 35. Walsh WR, Vizesi F, Michael D et al. Beta-TCP bone graft substitutes in a bilateral rabbit tibial defect model. Biomaterials 29(3), 266–271 (2008).
  Medline CASGoogle Scholar
• 36. Moore WR, Graves SE, Bain GI. Synthetic bone graft substitutes. ANZ J. Surg. 71(6), 354–361 (2001).
  Medline CASGoogle Scholar
• 37. Sferopoulos NK. Autograft transfer from the ipsilateral femoral condyle in depressed tibial plateau fractures. Open Orthop. J. 8, 310–315 (2014).• Found that that depressed tibial plateau fracture heals faster in patients treated with autologous bone than with bone substitute, indicating the potential of bone substitutes for biological improvement.
  Medline CASGoogle Scholar
• 38. Schatzker J, Home G, Waddell J. The Toronto experience with the supracondylar fracture of the femur, 1966-72. Injury 6(2), 113–128 (1974).
  Medline CASGoogle Scholar
• 39. Tscherne H, Lobenhoffer P. Tibial plateau fractures. Management and expected results. Clin. Orthop. Relat. Res. (292), 87–100 (1993).
  MedlineGoogle Scholar
• 40. Brown TD, Anderson DD, Nepola JV, Singerman RJ, Pedersen DR, Brand RA. Contact stress aberrations following imprecise reduction of simple tibial plateau fractures. J. Orthop. Res. 6(6), 851–862 (1988).
  Medline CASGoogle Scholar
• 41. Betz RR. Limitations of autograft and allograft: new synthetic solutions. Orthopedics 25(5 Suppl.), s561–s570 (2002).
  MedlineGoogle Scholar
• 42. Brodt MD, Swan CC, Brown TD. Mechanical behavior of human morselized cancellous bone in triaxial compression testing. J. Orthop. Res. 16(1), 43–49 (1998).
  Medline CASGoogle Scholar
• 43. Goff T, Kanakaris NK, Giannoudis PV. Use of bone graft substitutes in the management of tibial plateau fractures. Injury 44(Suppl. 1), S86–S94 (2013).
  MedlineGoogle Scholar
• 44. Ong JC, Kennedy MT, Mitra A, Harty JA. Fixation of tibial plateau fractures with synthetic bone graft versus natural bone graft: a comparison study. Ir. J. Med. Sci. 181(2), 247–252 (2012).
  Medline CASGoogle Scholar
• 45. Fan L, Yu Z, Li J, Dang X, Wang K. Immunoregulation effects of bone marrow-derived mesenchymal stem cells in xenogeneic acellular nerve grafts transplant. Cell Mol. Neurobiol. 34(7), 999–1010 (2014).
  MedlineGoogle Scholar
• 46. Cao W, Cao K, Cao J, Wang Y, Shi Y. Mesenchymal stem cells and adaptive immune responses. Immunol. Lett. 168(2), 147–153 (2015).
  Medline CASGoogle Scholar
• 47. Purandare B, Teklemariam T, Zhao L, Hantash BM. Temporal HLA profiling and immunomodulatory effects of human adult bone marrow- and adipose-derived mesenchymal stem cells. Regen. Med. 9(1), 67–79 (2014).
  CASGoogle Scholar
• 48. Wise AF, Williams TM, Rudd S, Wells CA, Kerr PG, Ricardo SD. Human mesenchymal stem cells alter the gene profile of monocytes from patients with Type 2 diabetes and end-stage renal disease. Regen. Med. 11(2), 145–158 (2016).
  CASGoogle Scholar
• 49. Nasef A, Ashammakhi N, Fouillard L. Immunomodulatory effect of mesenchymal stromal cells: possible mechanisms. Regen. Med. 3(4), 531–546 (2008).
  CASGoogle Scholar
• 50. Ben Nasr M, Vergani A, Avruch J et al. Co-transplantation of autologous MSCs delays islet allograft rejection and generates a local immunoprivileged site. Acta Diabetol. 52(5), 917–927 (2015).
  MedlineGoogle Scholar